Analysis of Tumor Deposit at the Fusion Site of the Right Gastric Mesentery and Left Gastric Mesentery in the Patients With Gastric Cancer Who Received Proximal Gastrectomy

ConditionGastric Carcinoma

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18-85

SponsorJichao Qin

About this trial

This study aims to evaluate the tumor deposit at the fusion site of the right gastric mesentery and left gastric mesentery in the patients with gastric cancer who received proximal gastrectomy.

Eligibility criteria

Qualifiers

Aged older than 18 years and younger than 85 years

Primary gastric adenocarcinoma confirmed by preoperative pathology result

cT2-4aN0-3M0 at preoperative evaluation according to the American Joint 8 Committee on Cancer (AJCC) Cancer Staging Manual 8th Edition

Patients undergoing proximal gastrectomy with D2 lymphadenectomy plus complete mesogastric excision

Disqualifiers

Negative preoperative biopsy

Too late tumour stage or metastasis (cT4b/M1)

BMI>30 kg/m2

previous neoadjuvant chemotherapy or radiotherapy

Trial design

Treatments tested in this trial

In addition to routine diagnosis and treatment, no additional intervention measures were taken.

Treatment groups

100 Participants

are divided into 1 treatment group

Sponsors and collaborators

Jichao Qin

Lead sponsor

First Affiliated Hospital of Zhejiang University

Sponsor institution

Source ClinicalTrials.gov